Lutein by Scleral Iontophoresis in AMD

Lutein by Scleral Iontophoresis in Patients With Stage 3 Age-Related Macular Degeneration

NCT06925893•Federico II University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Stage 3 AMD

Locations

Italy

Locations (1)

Federico II University

Naples, Italy

Key Dates

Start Date

November 1, 2024

Primary Completion Date

December 1, 2024

Completion Date

December 1, 2025

Last Updated

April 13, 2025

Contacts

Ciro Costagliola, Director Of Ophthalmology Unit

CONTACT

+390817462394 ciro.costagliola@unina.it

Sponsors

Lead Sponsor

Federico II University

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 13, 2025Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions